Osmosis Investment Management UK Ltd Invests $2.87 Million in CME Group Inc. $CME

Osmosis Investment Management UK Ltd bought a new stake in CME Group Inc. (NASDAQ:CME) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 13,014 shares of the financial services provider’s stock, valued at approximately $2,874,000.

A number of other institutional investors have also modified their holdings of the stock. Northwestern Mutual Investment Management Company LLC lifted its holdings in CME Group by 0.3% during the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after buying an additional 37 shares during the last quarter. Rehmann Capital Advisory Group grew its holdings in CME Group by 4.3% in the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after buying an additional 37 shares in the last quarter. Endowment Wealth Management Inc. increased its holdings in shares of CME Group by 4.4% during the fourth quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock valued at $244,000 after purchasing an additional 38 shares during the period. NBT Bank N A NY increased its stake in CME Group by 2.3% during the 1st quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock valued at $492,000 after buying an additional 38 shares during the period. Finally, Resonant Capital Advisors LLC increased its stake in shares of CME Group by 3.8% during the first quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider’s stock valued at $317,000 after acquiring an additional 39 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Performance

CME Group stock opened at $274.98 on Monday. CME Group Inc. has a 12 month low of $218.31 and a 12 month high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a market cap of $98.88 billion, a P/E ratio of 23.32, a P/E/G ratio of 3.27 and a beta of 0.23. The company’s fifty day simple moving average is $251.17 and its 200-day simple moving average is $279.57.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.08. The business had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.CME Group’s quarterly revenue was up .8% compared to the same quarter last year. During the same period last year, the company earned $2.96 earnings per share. As a group, sell-side analysts forecast that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be paid a dividend of $1.30 per share. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. CME Group’s dividend payout ratio (DPR) is 44.11%.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Bank of America boosted their price target on shares of CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a research report on Thursday, July 23rd. JPMorgan Chase & Co. lifted their price target on CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a research note on Thursday, July 23rd. Deutsche Bank Aktiengesellschaft downgraded CME Group from a “buy” rating to a “hold” rating and cut their price objective for the stock from $286.00 to $270.00 in a report on Wednesday. Piper Sandler reduced their price objective on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a research note on Wednesday, July 15th. Finally, Morgan Stanley raised their target price on shares of CME Group from $324.00 to $330.00 and gave the stock an “overweight” rating in a report on Thursday, July 23rd. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, CME Group has a consensus rating of “Hold” and an average price target of $288.56.

Insider Activity

In other news, Director William R. Shepard purchased 325 shares of the stock in a transaction that occurred on Thursday, June 25th. The stock was acquired at an average price of $230.57 per share, with a total value of $74,935.25. Following the purchase, the director owned 260,442 shares in the company, valued at $60,050,111.94. This represents a 0.12% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.30% of the stock is currently owned by corporate insiders.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.